Published in Hypertension on January 01, 1998
Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis. Clin Exp Immunol (2005) 1.64
Homocysteine stimulates nuclear factor kappaB activity and monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells: a possible role for protein kinase C. Biochem J (2000) 0.95
Curcumin improves prostanoid ratio in diabetic mesenteric arteries associated with cyclooxygenase-2 and NF-κB suppression. Diabetes Metab Syndr Obes (2010) 0.79
Glucose downregulation of PKG-I protein mediates increased thrombospondin1-dependent TGF-{beta} activity in vascular smooth muscle cells. Am J Physiol Cell Physiol (2010) 0.78
Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation (1999) 8.04
Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial. JAMA (1996) 4.03
Diabetes mellitus and hypertension. Hypertension (1992) 1.93
Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab (2001) 1.93
Altered platelet calcium metabolism as an early predictor of increased peripheral vascular resistance and preeclampsia in urban black women. N Engl J Med (1990) 1.80
Diabetes mellitus: a disease of abnormal cellular calcium metabolism? Am J Med (1994) 1.74
Insulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease. J Mol Cell Cardiol (1999) 1.61
Prevalence of osteoporosis in women: variation with skeletal site of measurement of bone mineral density. Endocr Pract (2001) 1.49
Clinical review 145: Pleiotropic effects of statins: lipid reduction and beyond. J Clin Endocrinol Metab (2002) 1.47
Plasma norepinephrine responses to posture and isometric exercise increase with age in the absence of obesity. J Gerontol (1983) 1.46
Erythrocyte cation metabolism in preeclampsia. Am J Obstet Gynecol (1989) 1.44
Sex- and age-related antihypertensive effects of amlodipine. The Amlodipine Cardiovascular Community Trial Study Group. Am J Cardiol (1996) 1.41
A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks. Arch Intern Med (1990) 1.35
Antihypertensive therapy and the risk of type 2 diabetes mellitus. N Engl J Med (2000) 1.27
Alpha2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor. Mol Cell Endocrinol (2000) 1.23
Bovine fetuin is an inhibitor of insulin receptor tyrosine kinase. Life Sci (1997) 1.19
Metoclopramide stimulates prolactin secretion in man. J Clin Endocrinol Metab (1976) 1.18
17 beta-Estradiol attenuates voltage-dependent Ca2+ currents in A7r5 vascular smooth muscle cell line. Am J Physiol (1994) 1.16
Reduced contractile response to insulin and IGF-I in ventricular myocytes from genetically obese Zucker rats. Am J Physiol Heart Circ Physiol (2000) 1.10
Role of the sympathetic nervous system in blood pressure maintenance in obesity. J Clin Endocrinol Metab (1982) 1.09
Cost effectiveness of 24-hour ambulatory blood pressure monitoring in evaluation and treatment of essential hypertension. Am J Hypertens (1994) 1.06
Downregulation of K(+) channel genes expression in type I diabetic cardiomyopathy. Biochem Biophys Res Commun (2001) 1.04
Enumeration of waterborne Escherichia coli with petrifilm plates: comparison to standard methods. J Environ Qual (2003) 1.04
Enhanced 24-hour norepinephrine and renin secretion in young patients with essential hypertension: relation with the circadian pattern of arterial blood pressure. Am J Cardiol (1985) 1.03
Acute airway obstruction due to a benign cervical goiter. Otolaryngol Head Neck Surg (1987) 1.02
Diabetes mellitus and diabetes-associated vascular disease. Trends Endocrinol Metab (2001) 1.00
High sacrectomy for locally recurrent rectal cancer: Can long-term survival be achieved? J Surg Oncol (2010) 0.99
Ambulatory blood pressure monitoring in a nonacademic setting. Effects of age and sex. Am J Hypertens (1992) 0.99
Effects of pioglitazone on calcium channels in vascular smooth muscle. Hypertension (1994) 0.99
Clinical review 91: Female sex hormones and cardiovascular disease in women. J Clin Endocrinol Metab (1997) 0.98
Altered inotropic response to IGF-I in diabetic rat heart: influence of intracellular Ca2+ and NO. Am J Physiol (1998) 0.97
Impairment of cardiopulmonary baroreflex after cardiac transplantation in humans. Circulation (1987) 0.97
Insulin attenuates vasopressin-induced calcium transients and a voltage-dependent calcium response in rat vascular smooth muscle cells. J Clin Invest (1991) 0.95
Salt sensitivity and systemic hypertension in the elderly. Am J Cardiol (1988) 0.95
Epidemiologic and clinical aspects of insulin resistance and hyperinsulinemia. Am J Med (1991) 0.95
Metabolism of exogenous human chorionic gonadotrophin in men. J Endocrinol (1979) 0.93
Hyperpigmentation, vitiligo, and Addison's disease. Cutis (1985) 0.93
Salt sensitivity in blacks. Salt intake and natriuretic substances. Hypertension (1988) 0.93
Leydig cell tumor induced hypercalcemia in the Fischer rat: morphometric and histochemical evidence for a humoral factor that activates osteoclasts. Am J Pathol (1982) 0.90
Cardiovascular disease in the diabetic woman. J Clin Endocrinol Metab (1999) 0.89
Hypertension symposium: newer topics on normal and abnormal blood pressure regulatory mechanisms. West J Med (1983) 0.89
Tamoxifen (estrogen antagonist) inhibits voltage-gated calcium current and contractility in vascular smooth muscle from rats. J Pharmacol Exp Ther (1996) 0.89
Dopaminergic mediation of the natriuretic response to volume expansion. J Lab Clin Med (1985) 0.89
Genetic mapping and functional studies of a natural inhibitor of the insulin receptor tyrosine kinase: the mouse ortholog of human alpha2-HS glycoprotein. Int J Exp Diabetes Res (2001) 0.88
Relative androgenicity, blood pressure levels, and cardiovascular risk factors in young healthy women. Am J Hypertens (1995) 0.88
Pathophysiology of male hypogonadism associated with endogenous hyperestrogenism. Evidence for dual defects in the gonadal axis. N Engl J Med (1985) 0.88
Circadian variation in plasma dopamine levels in man. J Endocrinol Invest (1984) 0.88
Influence of age on contractile response to insulin-like growth factor 1 in ventricular myocytes from spontaneously hypertensive rats. Hypertension (1999) 0.88
Blood pressure and hormone changes associated with weight reduction in the obese. Hypertension (1982) 0.88
Troglitazone reduces contraction by inhibition of vascular smooth muscle cell Ca2+ currents and not endothelial nitric oxide production. Diabetes (1997) 0.88
Insulin potentiates platelet-derived growth factor action in vascular smooth muscle cells. Endocrinology (1998) 0.87
Adrenal function following coronary bypass surgery. Am Heart J (1985) 0.87
Effects of metformin on tyrosine kinase activity, glucose transport, and intracellular calcium in rat vascular smooth muscle. Endocrinology (1996) 0.87
Insulin resistance, carbohydrate metabolism, and hypertension. Am J Hypertens (1991) 0.86
Metformin but not glyburide prevents high glucose-induced abnormalities in relaxation and intracellular Ca2+ transients in adult rat ventricular myocytes. Diabetes (1999) 0.86
Gender differences in vascular compliance in young, healthy subjects assessed by pulse contour analysis. J Clin Hypertens (Greenwich) (2001) 0.86
Inhibition of Rho protein stimulates iNOS expression in rat vascular smooth muscle cells. Am J Physiol Heart Circ Physiol (2000) 0.86
Aplysia egg-laying hormone increases excitatory input into a retractor muscle of the buccal mass. Brain Res (1982) 0.86
Dopaminergic modulation of aldosterone secretion in man is unaffected by glucocorticoids and angiotensin blockade. J Clin Endocrinol Metab (1981) 0.86
Role of cellular calcium metabolism in abnormal glucose metabolism and diabetic hypertension. Am J Med (1989) 0.85
Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: role of vascular nitric oxide. Endocrinology (1996) 0.85
Altered dopaminergic modulation of sympathetic nervous system activity in idiopathic edema. J Endocrinol Invest (1984) 0.85
Parathyroid carcinoma: diagnosis and management. Eur J Surg Oncol (2001) 0.85
Effects of high calcium intake on blood pressure and calcium metabolism in young SHR. Hypertension (1984) 0.85
Hyperinsulinemia, insulin resistance, and hyperglycemia: contributing factors in the pathogenesis of hypertension and atherosclerosis. Am J Hypertens (1993) 0.85
Comparison of metoclopramide with other dynamic tests of prolactin secretion. J Clin Endocrinol Metab (1976) 0.85
Reductions in plasma catecholamines and blood pressure during weight loss in obese subjects. Acta Endocrinol (Copenh) (1983) 0.85
An update on perioperative management of diabetes. Arch Intern Med (1999) 0.84
Reductions in total and extracellular water associated with calcium-induced natriuresis and the antihypertensive effect of calcium in blacks. Am J Hypertens (1988) 0.84
Dissociation of 24-hour catecholamine levels from blood pressure in older men. Hypertension (1986) 0.84
Troglitazone attenuates high-glucose-induced abnormalities in relaxation and intracellular calcium in rat ventricular myocytes. Diabetes (1996) 0.84
Vascular insulin abnormalities, hypertension, and accelerated atherosclerosis. Am J Kidney Dis (1993) 0.84
Using zebra mussels to monitor Escherichia coli in environmental waters. J Environ Qual (2001) 0.84
Hypertension in the elderly. Am J Med (1987) 0.84
Dopaminergic control of prolactin and blood pressure: altered control in essential hypertension. Hypertension (1982) 0.83
Dopaminergic control of plasma catecholamine and aldosterone responses to acute stimuli in normal man. J Clin Endocrinol Metab (1980) 0.83
Magnesium responsiveness to insulin and insulin-like growth factor I in erythrocytes from normotensive and hypertensive subjects. J Clin Endocrinol Metab (1998) 0.83
Dopaminergic modulation of renin release. Clin Exp Hypertens (1981) 0.83
Alpha2-Heremans Schmid glycoprotein inhibits insulin-stimulated Elk-1 phosphorylation, but not glucose transport, in rat adipose cells. Endocrinology (1998) 0.83
Behavioral state changes induced in Pleurobranchaea and Aplysia by serotonin. Behav Neural Biol (1982) 0.83
Growth hormone and prolactin secretion in Huntington's disease. Life Sci (1979) 0.83
Dopaminergic regulation of natriuretic response to acute volume expansion in dogs. Clin Sci (Lond) (1985) 0.83
In vivo and in vitro induction of germinal vesicle breakdown in a freshwater bivalve, the zebra mussel Dreissena polymorpha (Pallas). J Exp Zool (1994) 0.83
Insulin like growth factor 1 increases vascular smooth muscle nitric oxide production. Life Sci (1997) 0.82
Regulation of Na+,K(+)-ATPase gene expression by insulin in vascular smooth muscle cells. Am J Hypertens (1993) 0.82
Neuropeptide activation of an identifiable buccal ganglion motoneuron in Aplysia. Brain Res (1983) 0.82